Eris Lifesciences Ltd
Glimepiride (1mg) + Metformin (000mg) + Voglibose (0.3mg)
Glimisave MV 1.3F Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimisave MV 1.3F Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimisave MV 1.3F Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimisave MV 1.3F Tablet SR.
Glimisave MV 1.3F Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimisave MV 1.3F Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimisave MV 1.3F Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimisave MV 1.3F Tablet SR contains Glimepiride, Metformin, and Voglibose - all working together to treat type 2 diabetes mellitus (DM). This medication improves blood sugar control by helping the body use insulin effectively. It should be taken alongside a healthy diet and exercise routine for optimal results.
Common side effects include: Hypoglycemia (low blood sugar), Nausea, Diarrhea, Altered taste perception, Flatulence, Stomach pain, Headache, Skin rash, and respiratory tract infection.
Glimisave MV 1.3F Tablet SR should not be used by individuals with a known allergy to any of the ingredients or excipients, and it is also contraindicated for patients with: Moderate to severe kidney disease, inflammatory bowel diseases (IBD), colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimisave MV 1.3F Tablet SR with alcohol is not recommended as it can potentially worsen hypoglycemia (low blood sugar). Alcohol can lower your blood sugar level and increase the risk of lactic acidosis.
Yes, using Glimisave MV 1.3F Tablet SR can lead to hypoglycemia (low blood sugar). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heartbeat, and feelings of anxiety or shakiness. It is important to monitor your blood sugar levels regularly and keep glucose tablets, honey, or fruit juice on hand for quick access.
Store this medicine in its original packaging, tightly closed. Follow the instructions provided by your pharmacist or on the label for proper storage. Dispose of unused medication responsibly; ensure it is inaccessible to children, pets, and others.